Published in Blood on May 14, 2014
Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J Clin Oncol (2015) 1.84
Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study. JAMA Oncol (2015) 1.55
Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma. Cancer (2016) 0.83
The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia. Pharmacogenet Genomics (2017) 0.78
Socioeconomic differences in cancer survival among Swedish children. Br J Cancer (2016) 0.77
A randomized controlled trial testing an adherence-optimized Vitamin D regimen to mitigate bone change in adolescents being treated for acute lymphoblastic leukemia. Leuk Lymphoma (2017) 0.75
Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children's Oncology Group study. Blood (2017) 0.75
Decreased fetal hemoglobin over time among youth with sickle cell disease on hydroxyurea is associated with higher urgent hospital use. Pediatr Blood Cancer (2016) 0.75
Impact of NUDT15 polymorphisms on thiopurines-induced myelotoxicity and thiopurines tolerance dose. Oncotarget (2017) 0.75
It takes a village. Blood (2014) 0.75
Shorter Maintenance Therapy in Childhood Acute Lymphoblastic Leukemia: The Experience of the Prospective, Randomized Brazilian GBTLI ALL-93 Protocol. Front Pediatr (2016) 0.75
Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry. Blood (2017) 0.75
Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia. Leukemia (2017) 0.75
Adherence to medication. N Engl J Med (2005) 39.77
Treatment of acute lymphoblastic leukemia. N Engl J Med (2006) 11.30
Cytogenetics in acute leukemia. Blood Rev (2004) 9.99
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol (1996) 5.09
A review of adjusted estimators of attributable risk. Stat Methods Med Res (2001) 4.34
Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med (1997) 4.13
Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer (2008) 3.71
Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet (1990) 3.38
Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med (2003) 3.26
Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA (2003) 3.07
Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol (2000) 2.40
Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia. J Clin Oncol (1989) 2.24
Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood (1999) 2.18
Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood (2002) 2.17
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study. Blood (2012) 2.09
A reliable method for evaluating drug compliance in children with cancer. Cancer (1979) 2.00
Compliance of pediatric and adolescent cancer patients. Cancer (1986) 1.97
Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children. N Engl J Med (1990) 1.91
Health literacy explains racial disparities in diabetes medication adherence. J Health Commun (2011) 1.67
Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study. Clin Ther (2009) 1.55
Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group. J Clin Oncol (2012) 1.52
The electronic medication event monitor. Lessons for pharmacotherapy. Clin Pharmacokinet (1997) 1.47
Informal care and reciprocity of support are associated with HAART adherence among men in Baltimore, MD, USA. AIDS Behav (2011) 1.38
Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology. J Clin Oncol (1995) 1.34
Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res (2009) 1.33
Variable mercaptopurine metabolism in children with leukaemia: a problem of non-compliance? BMJ (1993) 1.28
Medication adherence among Latino and non-Latino white children with asthma. Pediatrics (2012) 1.25
Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance? Br J Cancer (1995) 1.25
Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetes. J Gen Intern Med (2012) 1.11
"You must take the medications for you and for me": family caregivers promoting HIV medication adherence in China. AIDS Patient Care STDS (2011) 1.05
Compliance with chemotherapy in childhood leukaemia in Africa. S Afr Med J (1989) 1.04
Assay of 6-mercaptopurine and its metabolites in patient plasma by high-performance liquid chromatography with diode-array detection. J Chromatogr B Biomed Sci Appl (1999) 1.04
Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia. Med Pediatr Oncol (1998) 1.03
Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users. JAMA Intern Med (2013) 0.97
The role of family caregivers in HIV medication adherence. AIDS Care (2006) 0.96
Medication adherence is associated with having a caregiver among cardiac patients. Ann Behav Med (2013) 0.84